Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
DSNKY DAIICHI SANKYO COMPANY LIMITED SPON ADR EA REPR 1 ORD JPY0.00 LEVEL I
32.7600.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/09/30(Q1)2022/06/30(FY)2022/03/31(Q4)2022/03/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-19.81% 31.7848 -47.33% 22.0357 -764.56% -18.0135 -764.56% -18.0135
Receivable Turnover(T)
-3.77% 3.6811 -1.98% 3.8645 17.85% 4.1904 17.85% 4.1904
Inventory Turnover(T)
-17.20% 1.4414 -13.82% 1.4872 -6.67% 1.6875 -6.67% 1.6875
Fixed Assets Turnover(T)
-3.49% 3.6739 -5.47% 3.569 -2.31% 3.6705 -2.31% 3.6705
Total Asset Rate(T)
2.40% 0.4948 1.53% 0.4871 5.64% 0.4853 5.64% 0.4853
ROIC
-22.89% 4.334% -26.15% 3.695% -2.78% 4.487% -2.78% 4.487%
ROE
-31.08% 4.520% -38.22% 3.776% -13.34% 5.107% -13.34% 5.107%
ROA
-33.15% 2.768% -39.59% 2.323% -14.20% 3.110% -14.20% 3.110%
FCF to Sales
46.77% 7.644% 18.65% 7.019% -55.03% 5.986% -55.03% 5.986%
FCF to Net Income
124.82% 136.621% 99.42% 147.193% -44.63% 93.388% -44.63% 93.388%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- 1.98% 6.833% -- --
ROA 5 Year Average
-- -- -- -- 1.50% 4.148% -- --
Average 5 Years ROIC
-- -- -- -- 2.44% 5.545% -- --
Profitability Ratios TTM
Gross Margin
5.30% 69.693% 3.31% 67.686% 2.05% 66.185% 2.05% 66.185%
Operating Margin
-16.05% 7.470% -23.80% 5.809% 5.45% 6.989% 5.45% 6.989%
Net Margin
-34.71% 5.595% -40.50% 4.769% -18.78% 6.409% -18.78% 6.409%
EBITDA Margin
-11.14% 0.135% -16.48% 0.1186% -5.65% 0.1316% -5.65% 0.1316%
R & D Expense Ratio
17.33% 26.880% 12.72% 26.490% 5.42% 24.900% 5.42% 24.900%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
4.25% 35.840% 2.30% 35.190% -0.92% 34.290% -0.92% 34.290%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-36.39% 6.944% -19.98% 10.211% -17.57% 10.591% -17.57% 10.591%
Total Assets to Common Equity
2.88% 165.476% 1.71% 163.867% 0.32% 164.442% 0.32% 164.442%
Debt to Asset Ratio
-21.69% 9.766% -18.72% 11.667% -16.27% 12.100% -16.27% 12.100%
Current Ratio
-9.94% 3.4041 -9.35% 3.3606 -5.13% 3.4034 -5.13% 3.4034
Quick Ratio
-12.00% 2.7382 -10.58% 2.6996 -6.02% 2.8095 -6.02% 2.8095
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- 4,831.30% 3.970% -- --
Revenue CAGR(5Y)
-- -- -- -- 469.96% 1.813% -- --
Net Income CAGR(3Y)
-- -- -- -- -231.06% -10.498% -- --
Net Income CAGR(5Y)
-- -- -- -- 390.39% 4.608% -- --
Dividend CAGR(3Y)
-- -- -- -- -53.92% 2.566% -- --
Dividend CAGR(5Y)
-- -- -- -- 8.30% 2.939% -- --
FCF 1 Year Growth
-- -- -- -- -363.00% -51.181% -- --
FCF CAGR(3Y)
-- -- -- -- 58.59% 35.001% -- --
FCF CAGR(5Y)
-- -- -- -- -200.52% -5.564% -- --
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
CEO: Mr. Sunao Manabe
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist